CMPC 2,4-dichloro-3-isocyanato-1,5-dimethoxy- Benzene
| Molecular formula | C9H7Cl2NO3 |
| Molecular weight | 248.06 |
| CAS NO. | 872511-32-5 |
| Description | API Intermediate: Infigratinib, sold under the brand name Truseltiq, is an anti-cancer medication used to treat cholangiocarcinoma (bile duct cancer). It was designated an orphan drug by the U.S. Food and Drug Administration (FDA) in 2019, and it was approved for medical use in the United States in May 2021. |
